It started in 1897, when the German chemist Felix Hoffman for the first time synthesized acetyl salicylic acid (aspirin) while working for the Bayer ... of the selected drug candidate following a set ...

On Wednesday morning, officials gathered at the large Bayer plant on West Stoever Avenue to mark a $43.6-million, ...

Bayer is boosting its precision oncology efforts with a molecular database from health tech firm ConcertAI.  | Bayer is ...

Bayer is lobbying U.S. states to adjust their regulations in the battle to control costly litigation targeting its herbicide ...

Bayer AG (Leverkusen, Germany) announced the grand opening of its new 70,000 square foot expansion at its Myerstown, ...

The idea that aspirin is such a “wonder drug” is the subject of intense research, but the picture is muddled. The notion that aspirin could have anti-cancer properties dates back decades.

The U.S. Food And Drug Administration (FDA) granted full approval to Bayer AG’s (OTC:BAYRY) Vitrakvi (larotrectinib) for adult and pediatric patients with solid tumors that have a neurotrophic ...

The expansion strengthens Bayer’s ability to deliver health-focused products more efficiently across North America.

FDA grants full approval to Bayer's Vitrakvi for NTRK fusion-positive solid tumors in adults and children. Clinical trials show a 60% overall response rate and median response duration of 43.3 ...

Bayer BAYRY announced that the FDA has granted full approval to oncology drug, Vitrakvi (larotrectinib), a first-in-class TRK inhibitor. The drug is now fully approved in the United States for ...

The beneficial thromboprophylactic effects of aspirin are based on inhibition of prostaglandin synthesis, the same mechanism by which the drug may cause adverse GI effects or other bleeding ...